Basic Info.
Trademark
XINHUA, JIHENG, WUYAO
Transport Package
25kg/Drum
Product Description
Metamizole or dipyrone, is a painkiller, spasm reliever and fever reliever. Like ibuprofen, it has anti-inflammatory effects. It is most commonly given by mouth or by injection. Although it is available over-the-counter in some countries, it is prescription or banned in other countries, due to its potential for adverse events, including agranulocytosis. It is in the ampyrone sulfonate family of medicines.
Dipyrone is a water soluble pyrazolone derivative available in oral, rectal and injectable forms. It has analgesic, antipyretic, antispasmodic, and anti-inflammatory properties. Dipyrone is used most commonly to treat severe pain, particularly, for pain associated with smooth muscle spasm or colic affecting the gastrointestinal, biliary or urinary tracts. It is useful for fever that is refractory to other treatment. Because of the risk of serious adverse effects, such as agranulocytosis, its use is justified only in serious situations where no alternative is available or suitable.
Product Name Metamizole Sodium Monohydrate(Metamizole Sodium,Analgin) Batch Number 2117090265 Quantity 1000Kg Mfg Site 10-1 Packing Specification 25Kg/drum Mfg Date 2017.09.29 Expiry Date 2020.09.28 Certificate No. 2117090265R1 Report Date 2017.10.05 Storage condition Protected from light, preserve in tight containers , Contents
Specification:EP8.1 :EP8.1 Results of analysis
RD-5-087 1 1 /: C/1 Add: Xiangtan Village,Liushi Street,Dongyang City,Zhejiang Province 322104,China. :,:322104,:0579-86773108 A ppearance
White or almost white crystalline powder
A lmost white crystalline powder
Identification
(1)Comparing with the spectrum obtained with CRS Conform
(2)Positive Conform
(3)Positive Conf orm (4)Reaction of sodium Conform
Appearance of solution
M eets the requirements
Conform
Acidity or alkalinity
M eets the requirements
Conform
Related substances
(1) Impurity C: not more than 0.5 C : 0.5% N ot detected (2) I mpurit y E : not more than 15% E : 0 15 0.04% (3) Unspecified impurities: for each impurity, not more than 0.05% : 0.05% 0.04% (4) Total impurities: not more than 0.5 : 0.5% Disregard limit: 0.03% : 0.03% 0. 09 Sulfate s
≤ 0.1% < 0.1% Heavy metals
≤ 0.002% < 0.0 02 Loss on drying
4.9~5.3% 5.2% Assay(dried substance) () 99.0%~101.0% 99.1% Solubility
Very soluble in water, sparingly soluble in ethanol (96 percent), practically insoluble in methylene chloride Conform |
About Us:
China Sinopharm International (Shanghai) Co., Ltd. is a comprehensive commercial service enterprise centering international pharmaceutical business.
It is a wholly-owned subsidiary under China Sinopharm International Corporation and is affiliated to China National Pharmaceutical Group Corporation (referred to as "Sinopharm Group"), a Fortune Global 500. Founded in 1985, the company has an net asset of nearly 200 million yuan. It has complete commercial facilities and 23,000 square meters of properties including an office building and shopping malls in Shanghai's West Nanjing Road commercial area and multiple warehouses. International business are carried out based on the platforms of Sinopharm Group and Sinopharm International Pharmaceutical and aims to spread China's high-quality pharmaceutical products and services to the world.
Through close cooperation with major domestic pharmaceutical companies, high-quality pharmaceutical products and overall solutions are provided to overseas customers. We are a well-known pharmaceutical enterprise in China with partners extending to more than 80 countries and regions around the world.
Address:
No. 293 Jiang Ning Road, Shanghai, China
Business Type:
Manufacturer/Factory, Trading Company
Business Range:
Health & Medicine
Management System Certification:
ISO 9001
Company Introduction:
China Sinopharm International (Shanghai) Co., Ltd. is a comprehensive commercial service enterprise centering international pharmaceutical business. It is a wholly-owned subsidiary under China Sinopharm International Corporation and is affiliated to China National Pharmaceutical Group Corporation (referred to as "Sinopharm Group"), a Fortune Global 500. Founded in 1985, the company has an net asset of nearly 200 million yuan. It has complete commercial facilities and 23, 000 square meters of properties including an office building and shopping malls in Shanghai′s West Nanjing Road commercial area and multiple warehouses. International business are carried out based on the platforms of Sinopharm Group and Sinopharm International Pharmaceutical and aims to spread China′s high-quality pharmaceutical products and services to the world. Through close cooperation with major domestic pharmaceutical companies, high-quality pharmaceutical products and overall solutions are provided to overseas customers. We are a well-known pharmaceutical enterprise in China with partners extending to more than 80 countries and regions around the world. We have long been focusing on the field of medicine and health. Our main business covers overseas registration and import and export of pharmaceutical products such as preparations, APIs, medical devices and diagnostic reagents; Export of pharmaceutical engineering equipment, production lines and technical services; Import and export of health products, food additives and plant extracts. In 2017, the company′s total import and export volume exceeded 300 million yuan. At present, we have obtained more than 20 overseas registration certificates for preparations, APIs and medical devices and assisted many domestic pharmaceutical companies for access to the international market. Over the years, the company has always adhered to idea to be "professional, efficient, cohesive, progressive" and undertakes the mission to "create value, serve for customers and cultivate employees". Our strategic goal is to place customers as our center and become a world-class pharmaceutical import and export enterprise.